We are live on ! Find out more
PPA

Parametric Portfolio Associates Portfolio holdings

AUM $190B
1-Year Est. Return 18.52%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+18.52%
3 Year Est. Return
+86.84%
5 Year Est. Return
+137.89%
10 Year Est. Return
AUM
$190B
AUM Growth
-$5.29B
Cap. Flow
+$4.62B
Cap. Flow %
2.43%
Top 10 Hldgs %
23.65%
Holding
3,846
New
220
Increased
2,219
Reduced
1,217
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 24.29%
2 Financials 13.33%
3 Healthcare 12.88%
4 Consumer Discretionary 10.38%
5 Industrials 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTIL icon
3451
Precision BioSciences
DTIL
$215M
$194K ﹤0.01%
2,098
-714
-25% -$97K
ENFN
3452
DELISTED
Enfusion, Inc.
ENFN
$194K ﹤0.01%
+15,251
New +$233K
RDUS
3453
DELISTED
Radius Health, Inc.
RDUS
$193K ﹤0.01%
21,819
-7,854
-26% -$59.5K
BLBD icon
3454
Blue Bird Corp
BLBD
$1.88B
$190K ﹤0.01%
10,071
-43
-0.4% -$783
MCRB icon
3455
Seres Therapeutics
MCRB
$51.3M
$190K ﹤0.01%
1,333
-825
-38% -$127K
VEON icon
3456
VEON
VEON
$4.19B
$189K ﹤0.01%
11,064
-241,646
-96% -$6.57M
BNFT
3457
DELISTED
Benefitfocus, Inc.
BNFT
$189K ﹤0.01%
14,993
-18,724
-56% -$200K
AVXL icon
3458
Anavex Life Sciences
AVXL
$277M
$188K ﹤0.01%
15,293
-32,828
-68% -$404K
EGY icon
3459
Vaalco Energy
EGY
$607M
$185K ﹤0.01%
+28,275
New +$148K
INSG icon
3460
Inseego
INSG
$72.3M
$185K ﹤0.01%
4,568
+3,132
+218% +$143K
LYEL icon
3461
Lyell Immunopharma
LYEL
$356M
$185K ﹤0.01%
1,835
+1,096
+148% +$133K
URG
3462
Ur-Energy
URG
$561M
$185K ﹤0.01%
115,422
+23,503
+26% +$33.3K
BFX
3463
DELISTED
BowFlex Inc.
BFX
$185K ﹤0.01%
44,898
+32,827
+272% +$163K
RADA
3464
DELISTED
Rada Electronic Industries Ltd
RADA
$185K ﹤0.01%
+13,286
New +$151K
ALHC icon
3465
Alignment Healthcare
ALHC
$2.83B
$184K ﹤0.01%
+16,362
New +$147K
AAIC
3466
DELISTED
Arlington Asset Investment Corp.
AAIC
$184K ﹤0.01%
53,064
-33,057
-38% -$114K
OCGN icon
3467
Ocugen
OCGN
$448M
$182K ﹤0.01%
55,238
-28,321
-34% -$99.5K
RSKD icon
3468
Riskified
RSKD
$833M
$182K ﹤0.01%
+30,171
New +$202K
ATCO
3469
DELISTED
Atlas Corp.
ATCO
$181K ﹤0.01%
12,311
+255
+2% +$3.78K
NNOX icon
3470
Nano X Imaging
NNOX
$65.2M
$176K ﹤0.01%
+16,221
New +$173K
KLDO
3471
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$174K ﹤0.01%
105,446
+38,818
+58% +$69.3K
AMSC icon
3472
American Superconductor
AMSC
$1.38B
$173K ﹤0.01%
22,766
+11,566
+103% +$99K
PPTA
3473
Perpetua Resources
PPTA
$3.14B
$173K ﹤0.01%
42,292
-39,334
-48% -$157K
ADVM
3474
DELISTED
Adverum Biotechnologies
ADVM
$172K ﹤0.01%
13,164
-4,695
-26% -$68.7K
GOCO
3475
DELISTED
GoHealth
GOCO
$172K ﹤0.01%
9,709
-13,222
-58% -$412K

Similar funds

Parametric Portfolio Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Parametric Portfolio Associates held 3,846 positions worth $190B, down 2.7% from $195B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Parametric Portfolio Associates's Q1 2022 filing shows 220 new, 2,219 increased, 1,217 reduced and 173 closed positions. Its largest new stake was Shell: 4,108,679 shares worth $226M. The largest sale was iShares Core S&P 500 ETF, an estimated $679M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Parametric Portfolio Associates's largest Q1 2022 buy was Shell: 4,108,679 shares worth $226M.
  • Parametric Portfolio Associates added most to Microsoft in Q1 2022, an estimated $329M increase.
  • Parametric Portfolio Associates's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $679M.
  • Parametric Portfolio Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $175M.
  • Parametric Portfolio Associates's ten largest holdings make up 24% of its $190B portfolio in Q1 2022.
  • Parametric Portfolio Associates opened 220 new positions and closed 173 in Q1 2022.
  • Parametric Portfolio Associates's portfolio value fell 2.7% quarter-over-quarter to $190B.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.